Mpi-Congenital Disorder of Glycosylation has emerging NIH research funding with 2 grants totaling $1.6M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Mpi-Congenital Disorder of Glycosylation. Strongest funded area: Clinical Research. Largest gap: Translational / Drug Development.
5 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for MPI-congenital disorder of glycosylation. Existing research activity suggests this may be a viable area for grant applications.
7 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for MPI-congenital disorder of glycosylation. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Mpi-Congenital Disorder of Glycosylation as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Mpi-Congenital Disorder of Glycosylation.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.